Terrence Connolly retired from the partnership on March 31, 2018. He was a partner in the New York office of Latham & Watkins and a member of the Litigation & Trial Department and the Intellectual Property and Antitrust Litigation Practices. Mr. Connolly focused on complex patent, copyright, trademark, and antitrust litigation.
Mr. Connolly has represented several pharmaceutical manufacturers in multiple Hatch-Waxman patent cases in the federal courts of New York, New Jersey, and Delaware.
Mr. Connolly is a member of the Second and Ninth US Circuit Courts of Appeals and the US Court of Appeals for the Federal Circuit. He is also a member of the US District Courts for the Southern, Eastern, and Western Districts of New York and the Western District of Washington. He is a member of the Program Committee of the Federal Bar Council and of the American Intellectual Property Law Association (AIPLA).
Mr. Connolly's representative matters include:
- CIMA Labs v. Orchid Chemicals & Pharmaceuticals and Schering Corp. v. Zydus Pharmaceuticals, USA - Mr. Connolly was co-lead counsel for Orchid Chemicals in these Hatch-Waxman patent infringement suits involving orally disintegrating desloratadine (Clarinex®) tablets and immediate release desloratadine (Clarinex®) tablets. Each case settled favorably following motion practice
- Purdue Pharma v. Ranbaxy et al. and Purdue Pharma v. Actavis et al. - Mr. Connolly is co-lead counsel for Actavis in these Hatch-Waxman patent cases involving Oxycodone ER® (Oxycontin ER®) tablets
- Rackman v. Nintendo - Mr. Connolly obtained summary judgment of noninfringement for Nintendo in a public key cryptography patent case in the US District Court for the Southern District of New York
- Gussin v. Nintendo - Mr. Connolly obtained summary judgment of noninfringement for Nintendo in a video art generation system patent infringement case in the US District Court for the Central District of California